GLUT1 is associated with higher grade, proliferation, as well as poorer prognosis in breast cancer [130, 131], although no link was observed between GLUT1 expression in breast cancer and background obesity or diabetes in one small study [132]. Here, SLC2A1 is linked to obesity disorder.